RSV, and norovirus are spreading at high levels in the U.S., causing overlapping symptoms like fever, fatigue, and nausea.

According to January 31, 2025 data posted by the Maricopa County Department of Public Health’s Respiratory Virus Surveillance ...

The following is a summary of “Hospital and mortality burden of COVID-19 compared with influenza in Denmark: a national observational cohort study, 2022–24,” published in the January 2025 issue of ...

Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance ...

Children with rheumatic diseases may face increased risks for COVID-19-related hospitalization, particularly those using glucocorticoids, rituximab, or mycophenolate.

The risk of developing RDS was significantly increased among newborns born to mothers with confirmed COVID-19 infection during pregnancy.

RSV, respiratory syncytial virus, usually peaks in December and January while infecting the nose, throat and lungs, usually ...

Even a mild infection with COVID-19 can promote clogged arteries, increasing the risk of heart attack in some people, a new ...

Leukocyte count an independent predictor of postacute sequelae of severe acute respiratory coronavirus 2 infection in postmenopausal women.

COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during the 2022 to 2023 season.

Compared with adults aged 65 and older, those aged 18 to 64 are more affected by long COVID neurologic symptoms.

The “Epicovid 2.0” study shows that the “impacts of the pandemic are great and long-lasting” and that it has “exacerbated ...